Identification of gastric cancer stem cells using the cell surface marker CD44

Stem Cells

Volumn 27, Issue 5, 2009, Pages 1006-1020

  Takaishi, Shigeo ^a   Okumura, Tomoyuki ^a,b   Tu, Shuiping ^a   Wang, Sophie S W ^a,c   Shibata, Wataru ^a   Vigneshwaran, Ramanathan ^a   Gordon, Shanisha A K ^a   Shimada, Yutaka ^b   Wang, Timothy C ^a,d  

^a College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF TOYAMA   (Japan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

CD44; Neoplastic stem cell biology; Serum free media; Severe combined immunodeficiency mice

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD133 ANTIGEN; CD24 ANTIGEN; CELL SURFACE MARKER; HERMES ANTIGEN; SHORT HAIRPIN RNA; STAGE SPECIFIC EMBRYO ANTIGEN 1; STAGE SPECIFIC EMBRYO ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENICITY; CELL ASSAY; CELL DEATH; CELL DIFFERENTIATION; CELL POPULATION; CELL RENEWAL; COLONY FORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; SCID MOUSE; STOMACH CANCER; TUMOR GROWTH; TUMOR SPHEROID;

ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; CULTURE MEDIA, SERUM-FREE; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; HUMANS; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; RNA, SMALL INTERFERING; SPHEROIDS, CELLULAR; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 66149175569     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.30     Document Type: Article

References (58)

1. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007;117:60-69.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Takaishi S, Okumura T, Wang TC. Gastric cancer stem cells. J Clin Oncol 2008;26:2876-2882.
4. Houghton J, Morozov A, Smirnova I et al. Stem cells and cancer. Semin Cancer Biol 2007;17:191-203. (Pubitemid 46415739)
5. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994;367:645-648. (Pubitemid 24067706)
6. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737. (Pubitemid 27298715)
7. Al-Hajj M, Wicha MS, Benito-Hernandez A et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988. (Pubitemid 36418143)
8. Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-5828. (Pubitemid 37187480)
9. Lobo NA, Shimono Y, Qian D et al. The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007;23:675-699.
10. Collins AT, Berry PA, Hyde C et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-10951. (Pubitemid 41713363)
11. Fang D, Nguyen TK, Leishear K et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005;65:9328-9337. (Pubitemid 41508000)
12. Schatton T, Murphy GF, Frank NY et al. Identification of cells initiating human melanomas. Nature 2008;451:345-349.
13. O'Brien CA, Pollett A, Gallinger S et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-110. (Pubitemid 46067310)
14. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-115. (Pubitemid 46067311)
15. Dalerba P, Dylla SJ, Park IK et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104:10158-10163. (Pubitemid 47175279)
16. Ma S, Chan KW, Hu L et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007;132:2542-2556. (Pubitemid 46890873)
17. Yang ZF, Ho DW, Ng MN et al. Significance of CD90(+) cancer stem cells in human liver cancer. Cancer Cell 2008;13:153-166.
18. Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037. (Pubitemid 46270758)
19. Hermann PC, Huber SL, Herrler T et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323. (Pubitemid 47355323)
20. Prince ME, Sivanandan R, Kaczorowski A et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007;104:973-978. (Pubitemid 46154721)
21. Eramo A, Lotti F, Sette G et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15:504-514.
22. Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells - Perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-9344. (Pubitemid 44623625)
23. Vermeulen L, Sprick MR, Kemper K et al. Cancer stem cells - Old concepts, new insights. Cell Death Differ 2008;15:947-958.
24. Szulc J, Aebischer P. Conditional gene expression and knockdown using lentivirus vectors encoding shRNA. Methods Mol Biol 2008;434:291-309.
25. Wang TC, Dangler CA, Chen D et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47. (Pubitemid 30020371)
26. Fenderson BA, De Miguel MP, Pyle AD et al. Staining embryonic stem cells using monoclonal antibodies to stage-specific embryonic antigens. Methods Mol Biol 2006;325:207-224.
27. Ponta H, Sherman L, Herrlich PA. CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003;4:33-45. (Pubitemid 36077255)
28. Vargo-Gogola T, Rosen JM. Modelling breast cancer: One size does not fit all. Nature Rev Cancer 2007;7:659-672. (Pubitemid 47327411)
29. Arima N, Yamashita Y, Nakata H et al. Presence of histamine H2-receptors on human gastric carcinoma cell line MKN-45 and their increase by retinoic acid treatment. Biochem Biophys Res Commun 1991;176:1027-1032.
30. Du L, Wang H, He L et al. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008;14:6751-6760.
31. Hadnagy A, Gaboury L, Beaulieu R et al. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006;312:3701-3710. (Pubitemid 44633895)
32. Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715.
33. Barker N, van Es JH, Kuipers J et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-1007. (Pubitemid 350014593)
34. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008;40:915-920.
35. May R, Riehl TE, Hunt C et al. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 2008;26:630-637.
36. Wielenga VJ, Smits R, Korinek V et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999;154:515-523. (Pubitemid 29094101)
37. Jin L, Hope KJ, Zhai Q et al. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006;12:1167-1174. (Pubitemid 44527352)
38. Krause DS, Lazarides K, von Andrian UH et al. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006;12:1175-1180. (Pubitemid 44527353)
39. Zeilstra J, Joosten SP, Dokter M et al. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Cancer Res 2008;68:3655-3661.
40. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med 2001;7:213-221. (Pubitemid 32822893)
41. Kelly PN, Dakic A, Adams JM et al. Tumor growth need not be driven by rare cancer stem cells. Science 2007;317:337.
42. Marx J. Molecular biology. Cancer's perpetual source?Science 2007;317:1029-1031.
43. Quintana E, Shackleton M, Sabel MS et al. Efficient tumour formation by single human melanoma cells. Nature 2008;456:593-598.
44. Shmelkov SV, Butler JM, Hooper AT et al. CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. J Clin Invest 2008;118:2111-2120.
45. Goodell MA, Brose K, Paradis G et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806. (Pubitemid 26134320)
46. Asakura A, Seale P, Girgis-Gabardo A et al. Myogenic specification of side population cells in skeletal muscle. J Cell Biol 2002;159:123-134. (Pubitemid 35191524)
47. Alvi AJ, Clayton H, Joshi C et al. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 2003;5:R1-R8.
48. Shimano K, Satake M, Okaya A et al. Hepatic oval cells have the side population phenotype defined by expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J Pathol 2003;163:3-9. (Pubitemid 36759585)
49. Dekaney CM, Rodriguez JM, Graul MC et al. Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology 2005;129:1567-1580. (Pubitemid 41597397)
50. Ono M, Maruyama T, Masuda H et al. Side population in human uterine myometrium displays phenotypic and functional characteristics of myometrial stem cells. Proc Natl Acad Sci USA 2007;104:18700-18705. (Pubitemid 350210760)
51. Hirschmann-Jax C, Foster AE, Wulf GG et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004;101:14228-14233.
52. Chiba T, Kita K, Zheng YW et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006;44:240-251. (Pubitemid 44049156)
53. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 2006;103:11154- 11159. (Pubitemid 44156488)
54. Patrawala L, Calhoun T, Schneider-Broussard R et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005;65:6207-6219. (Pubitemid 40994406)
55. Burkert J, Otto WR, Wright NA. Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 2008;214:564-573.
56. Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568-1571. (Pubitemid 39564955)
57. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: A new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005;128:1567-1578. (Pubitemid 40692553)
58. Qiao XT, Ziel JW, McKimpson W et al. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology 2007;133:1989-1998. (Pubitemid 350180818)